Kanso Diagnostics

Molecular Testing Platform

Health Tech & Life Sciences
Active
Seed Or Yehuda Founded 2022
Total raised
$1.5M
Last: SAFE 2024-07
Stage
Seed
Founded
2022
Headcount
7
HQ
Or Yehuda
Sector
Health Tech & Life Sciences

About

Kanso diagnostics develop a molecular testing platform for diagnosis of bacterial and viral infections. The company's solution aims to change the contemporary diagnostics experience, and the platform facilitates the at-home medical revolution, ensuring accessibility and ease of use. Kanso's novel technology accurately detects multiple pathogens and genetic biomarkers from a single sample, minimizing diagnosis time-to-results from days to minutes. This proprietary technology offers PCR-grade accuracy and rapid home testing convenience, providing an end-to-end solution for diagnosing bacterial and viral infections, available anywhere and anytime.

Funding history · 2 rounds · $1.5M total

2024-07
SAFE Undisclosed
2023-06
Seed $1.5M

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

When was Kanso Diagnostics founded?
Kanso Diagnostics was founded in March 2022.
What is Kanso Diagnostics' primary focus?
Kanso Diagnostics develops a molecular testing platform for diagnosing bacterial and viral infections.
How much funding has Kanso Diagnostics raised in total?
Kanso Diagnostics has raised a total of $1,500,000.
Which investors participated in Kanso Diagnostics' Seed round?
In June 2023, Kanso Diagnostics closed a Seed round with investments from Peregrine Ventures and Becton Dickinson.
What was Kanso Diagnostics' most recent funding activity?
Kanso Diagnostics had a SAFE funding round in July 2024.
Has Kanso Diagnostics received any grants?
Yes, Kanso Diagnostics received a grant from the IIA in July 2024.
How many employees does Kanso Diagnostics currently have?
Kanso Diagnostics currently has 7 employees.
What is the current product stage of Kanso Diagnostics' technology?
Kanso Diagnostics' product is currently in the alpha stage.
Does Kanso Diagnostics hold any patents?
Yes, Kanso Diagnostics holds 1 patent.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesAssistive DevicesDiagnostics Devices
Technologies
BiologicalsMicroorganismsGenesMolecules
Target customers
Healthcare & Life SciencesHealthcarePatientsInsurance CompaniesProvidersMedical Devices IndustryMedical EquipmentLife SciencesBiotechnology
Business model
B2B2CB2B

Highlights

1 PatentsVerified

Tags

molecular-biologydiagnosticsinfectious-diseasebiotechnology